ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Solent Multiple Sclerosis Therapies Ltd

Solent Multiple Sclerosis Therapies Ltd is an active company incorporated on 29 January 1988 with the registered office located in Portsmouth, Hampshire. Solent Multiple Sclerosis Therapies Ltd was registered 37 years ago.
Status
Active
Active since 35 years ago
Company No
02215154
Private limited by guarantee without share capital
Age
37 years
Incorporated 29 January 1988
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 12 January 2025 (7 months ago)
Next confirmation dated 12 January 2026
Due by 26 January 2026 (4 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Apr31 Mar 2025 (12 months)
Accounts type is Total Exemption Full
Next accounts for period 31 March 2026
Due by 31 December 2026 (1 year 3 months remaining)
Contact
Address
Bradbury House 56 Hewett Road
North End
Portsmouth
Hampshire
PO2 0QP
Same address for the past 17 years
Telephone
02392699116
Email
Available in Endole App
People
Officers
16
Shareholders
-
Controllers (PSC)
1
Director • PSC • Retired Accountant • British • Lives in England • Born in May 1964
Director • Secretary • Financial Consultant • British • Lives in England • Born in May 1963
Director • Retired • British • Lives in England • Born in May 1955
Director • Retired Headteacher • British • Lives in England • Born in Apr 1949
Director • Retired Teacher • British • Lives in England • Born in Jul 1949
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Financials
Net Assets, Total Assets & Total Liabilities (2015–2025)
Period Ended
31 Mar 2025
For period 31 Mar31 Mar 2025
Traded for 12 months
Cash in Bank
£146.59K
Increased by £762 (+1%)
Turnover
£156.31K
Increased by £9.04K (+6%)
Employees
Unreported
Same as previous period
Total Assets
£359.27K
Decreased by £9.05K (-2%)
Total Liabilities
-£8.28K
Increased by £2.34K (+39%)
Net Assets
£350.99K
Decreased by £11.39K (-3%)
Debt Ratio (%)
2%
Increased by 0.69% (+43%)
Latest Activity
Lena Mary Clarke Resigned
1 Month Ago on 18 Jul 2025
Susan Anne Emery Resigned
3 Months Ago on 2 Jun 2025
Full Accounts Submitted
3 Months Ago on 28 May 2025
Confirmation Submitted
7 Months Ago on 22 Jan 2025
Mr Kenneth William Ebbens Appointed
9 Months Ago on 15 Nov 2024
Robert Derek Clive Hayter (PSC) Appointed
12 Months Ago on 9 Sep 2024
Mrs Karen Silman Appointed
1 Year 1 Month Ago on 19 Jul 2024
Sylvie Irene Stroud Resigned
1 Year 1 Month Ago on 19 Jul 2024
Gerald Woodhouse (PSC) Resigned
1 Year 1 Month Ago on 19 Jul 2024
Gerald Woodhouse Resigned
1 Year 1 Month Ago on 19 Jul 2024
Get Credit Report
Discover Solent Multiple Sclerosis Therapies Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Termination of appointment of Lena Mary Clarke as a director on 18 July 2025
Submitted on 24 Jul 2025
Termination of appointment of Susan Anne Emery as a director on 2 June 2025
Submitted on 12 Jun 2025
Total exemption full accounts made up to 31 March 2025
Submitted on 28 May 2025
Confirmation statement made on 12 January 2025 with no updates
Submitted on 22 Jan 2025
Appointment of Mr Kenneth William Ebbens as a director on 15 November 2024
Submitted on 22 Nov 2024
Notification of Robert Derek Clive Hayter as a person with significant control on 9 September 2024
Submitted on 9 Sep 2024
Termination of appointment of Gerald Woodhouse as a director on 19 July 2024
Submitted on 30 Aug 2024
Cessation of Gerald Woodhouse as a person with significant control on 19 July 2024
Submitted on 30 Aug 2024
Termination of appointment of Sylvie Irene Stroud as a director on 19 July 2024
Submitted on 30 Aug 2024
Termination of appointment of David Revill as a director on 19 July 2024
Submitted on 30 Aug 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year